How medspas are valued, and what moves the number.
Most medspa sales are priced as a multiple of adjusted EBITDA. That multiple depends on scale, recurring revenue, and how much of the work depends on the owner. One industry review puts medspas under $4 million in revenue at about 3 to 6 times EBITDA. It puts platforms over $20 million in revenue at about 7 to 12 times. So a buyer first restates the earnings, and then prices the risk that is left.
What buyers normalize
- Owner injector payA buyer resets the owner's pay to what it would cost to hire an injector for the same work. If the owner injects for a low salary, adjusted EBITDA drops.
- Medical director feesThe buyer checks that the medical director fee matches the agreement and the market. A fee that is missing or below market gets restated to what a new director would cost.
- One-time costsA build-out, a legal settlement, or a move can be added back if the records show it will not repeat. Every add-back needs a paper trail, because the buyer will ask for it.
- Discounts and promotionsHeavy discounting lifts revenue but cuts margin per treatment. Buyers look at net price per unit and per treatment, so deep promotions lower the earnings they will pay for.
- Personal expensesPersonal travel, family pay, and personal cars in the books become add-backs. Each one is an argument, so a clean P&L with few adjustments holds up better.
Memberships and injector dependency
Recurring membership revenue is the quality buyers pay the most for. A broker report citing FOCUS Investment Banking puts single-site clinics at about 3 to 6 times EBITDA. The same report says operators with recurring memberships and ties to dermatology or plastic surgery can reach 10 to 12 times. Buyers check that members stay, so churn and credit use matter as much as the member count.
Injector dependency pulls the multiple the other way. If one or two injectors bring in most of the revenue, the buyer asks what happens if they leave after the sale. That risk is highest when the owner is the main injector, because patients often follow the person.
Here is a simple example with round numbers. Say a medspa reports $500,000 of EBITDA, and the owner does most of the injecting for a $100,000 salary. If hiring an injector for that work would cost $250,000, the buyer cuts EBITDA to $350,000. At 5 times EBITDA, that one change takes $750,000 off the price.
Package balances, device leases, and ownership
Deferred package and gift card balances get close review in diligence. Many medspas book packages as revenue when they are sold. The buyer then restates past profit and also treats the unused balance as a debt, so the seller takes the hit twice. Books that carried the liability all along hold up without that fight.
Device leases and loans come up next. A laser on a lease is a fixed payment the buyer takes on, and some buyers count it as debt in the price. A clear list of each device, its payment, and its end date saves time late in the deal.
Ownership structure matters to buyers as well. Many states limit who may own a business that provides medical services. These limits are often called corporate practice of medicine rules, and medspas often address them through an MSO arrangement. Buyers review this setup closely, so owners should work with healthcare counsel well before a sale.
While counsel handles the legal side, getting the books ready for the buyer's review is a core part of our CFO advisory work for owners planning a sale.
Frequently asked
What multiple do medspas sell for?
It depends most on size and recurring revenue. One industry review puts medspas under $4 million in revenue at about 3 to 6 times EBITDA. It puts platforms over $20 million at about 7 to 12 times. Strong membership revenue and low dependence on the owner move a practice up within its range.
How do packages and gift cards affect a medspa sale?
A buyer treats unused packages, membership credits, and gift cards as treatments it must deliver after closing. That balance usually lowers the price or the cash paid at closing. If the packages were also booked as revenue when sold, past profit gets restated down as well.
Does it matter who legally owns my medspa?
It matters to buyers, because many states limit who may own a business that provides medical services. Buyers will review how your practice is set up, including any MSO arrangement. The rules differ by state, so talk to healthcare counsel about your own setup before you start a sale.
Medspa resource center
Or read the cross-practice version: growth and sale readiness in practice accounting →